Pyrrolo[3,4-c]pyrazole derivatives of formula (1) and pharmaceuticallyacceptable salts thereof, as defined in the specification, process for theirpreparation and pharmaceutical compositions comprising them are disclosed; thecompounds of the invention may be useful, in therapy, in the treatment ofdiseases associated with a disregulated protein kinase activity, like cancer.